CDC surveillance report describes arboviral disease cases in the U.S. during 2022U.S. health officials describe cases of mosquito and tick-borne diseases in 2022

This is a surveillance report from the Centers for Disease Control and Prevention (CDC) describing cases of arboviral disease in the United States during 2022. The report details the occurrence of these diseases across the country, but does not specify the total sample size of cases, the specific arboviruses involved, or provide comparative data from other years or locations.

No quantitative results, effect sizes, absolute numbers, or statistical measures (p-values or confidence intervals) are reported. The report's main outcome is the descriptive epidemiology of these cases. Information on safety, adverse events, or tolerability is not provided, as this is not an interventional study.

Key limitations include the descriptive nature of the report, which cannot establish causality or measure intervention effects. The funding sources and potential conflicts of interest are not reported. For clinical practice, this report serves as a source of public health surveillance information, reminding clinicians to consider arboviral diseases in differential diagnoses based on geographic and seasonal patterns, but it does not provide evidence to guide specific treatment decisions.